knowledge -WSS

knowledge

author：leisure time 2025-09-03 03:31:10 - browse：26939

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： UnitedHealth increases loan offers after Change Healthcare outage

WSS

Physicians and social media: If you see something, say something?

CDC concerned about possible undetected monkeypox spread in U.K.

Nurses recount patients attacks

Why we need to separate burnout from moral injury in health care

Health AI adoption puts security, privacy startups on investors' radar

Do masks work? RCTs can't tell us

hotspot

knowledge

focus

Hollywood unions extend contract negotiations for actors

Why are elite athletes different? Take a look at their microbes

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Cloning humans is technically possible. It's curious no one has tried

Hollywood unions extend contract negotiations for actors

Gene therapy has helped boys walk. Can scientists keep it that way?

Continuity nursing helped my family in our darkest PICU moments

Asbestos, a deadly carcinogen, banned by EPA

Hollywood unions extend contract negotiations for actors

Stop the failed accountable care organization experiment

Wikipedia

Orchard's therapy for neuron disease in children wins FDA approval

The battle over the Brookhaven Landfill on Long Island

Gene therapy has helped boys walk. Can scientists keep it that way?

Positive childhood experiences can help future health

Orchard's therapy for neuron disease in children wins FDA approval

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

knowledge

knowledge

hotspot

focus